June 16, 2020 Research Bulletin

Special Announcements

Cancer Center Update

The University of Colorado Cancer Center has results of the phase III Inter-B-NHL-ritux 2010 clinical trial that was published in the New England Journal of Medicine. It showed 95% three-year survival for pediatric patients with advanced B-cell non-Hodgkin lymphoma treated with the addition of anti-cancer immunotherapy rituximab to standard chemotherapy. 

CCTSI - Brand New Massive Open Online Course for Researchers

Drs. Anne Libby and Judy Regensteiner have developed a brand new course called Researcher Management & Leadership Training. This course is targeted to early career researchers and mentors who believe that modern scientific careers require management skills. Course content includes an action learning plan, and lessons on leadership, finance, and administration, management—starting, growing and maintaining teams and mentorship.       

Find the IT Resource That's Right for Your Research - New Research Tool

Created in partnership between the Office of the Vice Chancellor for Research, the School of Medicine and Office of Information Technology this website is designed to assist faculty and staff searching for IT computing resources available at the University of Colorado Anschutz Medical Campus. 

This website will allow you to compare each technology resource to find the best tools for your research computing needs.

Limited Submission Grant Opportunities

2021 Searle Scholars Program

The Searle Scholars Program is a limited submission award program which makes grants to selected academic and research institutions to support the independent research of outstanding early-career scientists who have recently been appointed as assistant professors on a tenure-track appointment. Grants are $300,000 for a three-year term with $100,000 payable each year of the grant, subject to the receipt of acceptable progress reports. Generally, the program makes 15 new grants annually. 

• Limited to one nomination per institution
• Application deadline September 30
• Materials due to Internal Review Committee July 2   

FY2021 NIH Director’s Early Independence Award (DP5 - Clinical Trial Optional)

RFA RM-20-014

Supports outstanding junior scientists with the intellect, scientific creativity, drive, and maturity to bypass the traditional postdoctoral training period and launch an independent research career. Applicants must have recently completed or will soon complete her/his doctoral degree or clinical training and have the support and guarantee of an independent research position from a host institution. 

• Limited to two applications per institution
• Materials due to Internal Review Committee June 26
• Application deadline: September 4   

FY2021 NIH Director’s Early Independence Award (DP5 - Clinical Trial Optional): COVID-19 Proposals

RFA RM-20-021

Supports outstanding junior scientists with the intellect, scientific creativity, drive, and maturity bypass the traditional postdoctoral training period and launch an independent research career. Applicants must have recently completed or will soon complete her/his doctoral degree or clinical training and have the support and guarantee of an independent research position from a host institution.  Proposal must be relevant to COVID-19 prevention, preparation, or response

• Limited to two applications per institution
• Materials due to Internal Review Committee June 26 
• Application deadline: September 4   

NIAMS Rheumatic Diseases Research Resource-based Centers (P30 -Clinical Trial Not Allowed)

RFA-AR-21-002

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) requests applications for the NIAMS Resource-based Centers Program (P30) for rheumatic disease research areas within its mission. The Resource-based Centers will provide critical research infrastructure, shared facilities, services, and/or resources to groups of investigators conducting research on rheumatic diseases. 

• Limited to one application per institution
• Materials due to Internal Review Committee July 6
• Optional LOI Due September 6
• Application deadline: October 6

Collaborative Research Opportunities

National Science Foundation (with NIH)
Ecology and Evolution of Infectious Diseases (EEID) Program

Program Objectives: The multi-agency Ecology and Evolution of Infectious Diseases program supports research on the ecological, evolutionary, and social drivers that influence the transmission dynamics of infectious diseases. The central theme of submitted projects must be the quantitative or computational understanding of pathogen transmission dynamics. The intent is discovery of principles of infectious disease transmission and testing mathematical or computational models that elucidate infectious disease systems. Projects should be broad, interdisciplinary efforts that go beyond the scope of typical studies. 

Deadline: November 18

Interested in collaborative research?  Do you have a collaborative research funding opportunity you would like to announce or are you searching for a collaborator on a specific proposal?     

Collaborations between research groups are growing, and the collaborating groups can be across the hall, University of Colorado campuses, the country, or the globe. Scholars or groups in different fields work together on interdisciplinary projects.   

The OVCR wants to offer this space on a bi-weekly basis for promotion of collaborative research funding opportunities (internal and external funding) and solicitations for prospective interdisciplinary collaborators for proposed funding applications.     

Send inquires to ResearchAdminComm@CUAnschutz.edu

NIH Funding Announcements

Just Released

The High-Risk High-Reward Research Program and other Common Fund programs are managed by the Office of Strategic Coordination, Division of Program Coordination, Planning, and Strategic Initiatives in the NIH Office of the Director, in partnership with the component NIH Institutes, Centers, and Offices. The NIH Common Fund encourages collaboration and supports a series of exceptionally high impact, trans-NIH programs. The National Institutes of Health (NIH) –“The Nation's Medical Research Agency” – includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. 

For more information about NIH and its programs, visit the NIH website.     

FY2021 NIH Director’s Transformative Research Award (R01 - Clinical Trial Optional)

RFA RM-20-013

Supports individuals or teams proposing that are inherently risky and untested but have the potential to create or overturn fundamental paradigms. An anonymized review process will be used. 

• Open to all career stages
• Application deadline: September 30   

FY2021 NIH Director’s Emergency Transformative Research Award (R01 - Clinical Trial Optional): COVID-19 Proposals

RFA RM-20-020

Supports individuals or teams proposing COVID-19-related projects that are inherently risky and untested but have the potential to create or overturn fundamental paradigms. An anonymized review process will be used. 

• Open to all career stages
• Application deadline: September 30

RFA for Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes (K18 Basic Experimental Studies with Humans Required)

New mid-career awards for BESH research from several NIH institutes available.

This bulletin is distributed on the 1st & 3rd Tuesday of the month for the CU Anschutz Research Community.     

Please click here if you wish to be added to this distribution.